Filing Details

Accession Number:
0001209191-22-053401
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-10-11 19:10:31
Reporting Period:
2022-10-06
Accepted Time:
2022-10-11 19:10:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604950 Scpharmaceuticals Inc. SCPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219014 M Scott Rocklage 501 2Nd Street, Suite 350
San Francisco CA 94107
No No Yes No
1240357 D John Diekman 501 2Nd Street, Suite 350
San Francisco CA 94107
No No Yes No
1589314 5Am Partners Iv, Llc 501 2Nd Street, Suite 350
San Francisco CA 94107
No No Yes No
1589315 5Am Ventures Iv, L.p. 501 2Nd Street, Suite 350
San Francisco CA 94107
No No Yes No
1593361 5Am Co-Investors Iv, L.p. 501 2Nd Street, Suite 350
San Francisco CA 94107
No No Yes No
1598549 J. Andrew Schwab 501 2Nd Street, Suite 350
San Francisco CA 94107
No No Yes No
1753000 5Am Opportunities I, L.p. 501 2Nd Street, Suite 350
San Francisco CA 94107
No No Yes No
1790778 5Am Opportunities I (Gp), Llc 501 2Nd Street, Suite 350
San Francisco CA 94107
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-10-06 30,457 $5.02 2,688,014 No 4 S Indirect By 5AM Ventures IV, L.P.
Common Stock Disposition 2022-10-06 1,269 $5.02 112,000 No 4 S Indirect By 5AM Co-Investors IV, L.P.
Common Stock Disposition 2022-10-06 5,808 $5.02 497,304 No 4 S Indirect By 5AM Opportunities I, L.P.
Common Stock Disposition 2022-10-10 456,413 $4.09 2,231,601 No 4 S Indirect By 5AM Ventures IV, L.P.
Common Stock Disposition 2022-10-10 19,017 $4.09 92,983 No 4 S Indirect By 5AM Co-Investors IV, L.P.
Common Stock Disposition 2022-10-10 87,036 $4.09 410,268 No 4 S Indirect By 5AM Opportunities I, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By 5AM Ventures IV, L.P.
No 4 S Indirect By 5AM Co-Investors IV, L.P.
No 4 S Indirect By 5AM Opportunities I, L.P.
No 4 S Indirect By 5AM Ventures IV, L.P.
No 4 S Indirect By 5AM Co-Investors IV, L.P.
No 4 S Indirect By 5AM Opportunities I, L.P.
Footnotes
  1. The shares are directly held by 5AM Ventures IV, L.P. ("Ventures IV"). 5AM Partners IV, LLC ("Partners IV") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein.
  2. The shares are directly held by 5AM Co-Investors IV, L.P. ("Co-Investors IV"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein.
  3. Shares are directly held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab is a managing member of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of such shares, except to the extent of its or his pecuniary interest therein.